IL17A and visceral leishmaniasis: Terrazas et al. (24) proposed that the IL-17A cytokine promotes susceptibility during experimental visceral leishmaniasis caused by L. donovani, by showing that IL-17A−/− mice were highly resistant to infection, with decreased parasite loads in the liver and spleen.